BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, January 25, 2026
Home » Authors » Mark McCarty

Articles by Mark McCarty

On This Date in History

Aug. 25, 2011
By Mark McCarty
On This Date: The birth of Emil Theodor Kocher, MD, Swiss surgical pioneer With the pace of change in the modern world and the emphasis on what's just around the corner, it can be edifying to take a moment to ask where we've been. And so we reflect for a moment on the work of Emil Theodor Kocher, MD, who was born 170 years ago on this date, Aug. 25, 1841. Kocher was born in Berne, Switzerland, where he earned his medical degree in 1865. He took the position of director of surgery at the Inselspital (Island Hospital), also in...
Read More

Washington roundup: NIH announces update to '95 guidance on financial conflict

Aug. 25, 2011
By Mark McCarty

Beckman hit with warning for validation and CAPA failures

Aug. 24, 2011
By Mark McCarty

Washington roundup: Two Dems want a GAO report on insulin pump security issues

Aug. 23, 2011
By Mark McCarty

Washington roundup: CDER guidance may ramp up imaging requirements in trials

Aug. 22, 2011
By Mark McCarty

Picking your poison: Wall Street or Venture Capital?

Aug. 21, 2011
By Mark McCarty
Life is full of choices, not all of them pleasant. For device makers of late, this definitely holds true. Firms in the venture capital end of things are not necessarily worried that VC has utterly abandoned med-tech, but it would appear that the start-up might find the going tough, even though firms with a little more development are getting more love from investors. As my colleague Amanda Pedersen noted in Medical Device Daily recently, a recent report by CB Insights (New York) indicates that the number of VC deals for med-tech continues to tail off, dropping from 184 in...
Read More

Washington roundup: OIG sees problems in more than $100M for lower limb prostheses

Aug. 19, 2011
By Mark McCarty

FDA publishes a strategic plan for regulatory science

Aug. 18, 2011
By Mark McCarty

FDA puts the brakes on provider training in clinical trial draft

Aug. 17, 2011
By Mark McCarty

Washington roundup: NSF funding for university med-tech research climbing

Aug. 16, 2011
By Mark McCarty
Previous 1 2 … 452 453 454 455 456 457 458 459 460 … 578 579 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 23, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing